⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GYRE News
Gyre Therapeutics, Inc. Common Stock
GYRE THERAPEUTICS: Kaskela Law Announces Investigation of Gyre Therapeutics, Inc. (GYRE) and Encourages Shareholders to Contact the Firm
globenewswire.com
GYRE
Form 8-K/A
sec.gov
GYRE
Form 8-K
sec.gov
GYRE
Gyre Therapeutics Announces China’s NMPA Grants Priority Review to the NDA for Hydronidone (F351) for CHB-Induced Liver Fibrosis Treatment
globenewswire.com
GYRE
Form 8-K
sec.gov
GYRE
Gyre Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
globenewswire.com
GYRE
Form 8-K
sec.gov
GYRE
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Gyre Therapeutics, Inc. (NASDAQ:GYRE) and Encourages Long-Term GYRE Shareholders to Contact the Firm
accessnewswire.com
GYRE
Form 8-K
sec.gov
GYRE
Gyre Therapeutics Enters into Agreement to Acquire Cullgen to Gain Targeted Protein Degradation Platform and Pipeline
globenewswire.com
GYRE